Different proliferative activity of the glandular and myoepithelial lineages in benign proliferative and early malignant breast diseases.
The aim of the present study was to explore cell biological characteristics of normal breast, benign proliferative breast diseases and noninvasive breast malignancies based on the recently published adult progenitor cell concept from our group. Here, we investigated the proliferative activity of CK5/14(+), CK8/18/19(+) and alpha-smooth muscle actin(+) cellular phenotypes encountered in normal mammary gland, in a series of usual ductal hyperplasias and early malignant breast diseases, such as atypical ductal and lobular hyperplasias, as well as ductal and lobular in situ carcinomas. Immunohistochemical double labeling was performed on frozen sections from diagnostic breast biopsies by using antibodies to basal cytokeratins (CK5/14), glandular cytokeratins (CK8/18/19), smooth muscle actin and the Ki-67 antigen (MIB1). Normal breast tissues and usual ductal hyperplasias were characterized by a heterogeneous cellular composition of the growth fraction. The proliferative cell compartment consisted of CK8/18/19(+) glandular and, in a variable proportion, CK5/14(+) progenitor phenotypes. In contrast, noninvasive breast malignancies were composed of a monotonous proliferation of CK 8/18/19(+) neoplastic glandular cells. These findings indicate a significant role of progenitor cells in the development of benign proliferative breast diseases and lend support to the view that malignant transformation in the human breast usually occurs in a cell committed to the glandular lineage. Our results provide cell kinetic support to the functional progenitor cell hypothesis, and we propose this concept as an operative model for understanding benign proliferative and malignant breast diseases.
Bánkfalvi
Agnes
A
Institute of Pathology, Münster University Hospital, Münster, Germany.
Ludwig
Andreas
A
De-Hesselle
Bettina
B
Buerger
Horst
H
Buchwalow
Igor B
IB
Boecker
Werner
W
D000199:Actins / Q000032:analysis; D000328:Adult; D000368:Aged; D001940:Breast / Q000737:chemistry / Q000473:pathology; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000378:metabolism / Q000473:pathology; D018275:Carcinoma, Lobular / Q000378:metabolism / Q000473:pathology; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry / Q000379:methods; D053547:Keratin-14; D053555:Keratin-5; D007633:Keratins / Q000032:analysis; D019394:Ki-67 Antigen / Q000032:analysis; D042361:Mammary Glands, Human / Q000737:chemistry / Q000473:pathology*; D008875:Middle Aged; D009130:Muscle, Smooth / Q000737:chemistry
D000199:Actins; C507540:KRT14 protein, human; C503940:KRT5 protein, human; D053547:Keratin-14; D053555:Keratin-5; D019394:Ki-67 Antigen; D007633:Keratins